DRUG · Unmapped registry intervention
Itacitinib
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
NCT02257619
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
NSCLC (Non-small Cell Lung Carcinoma)unresolved
Interventions
ItacitinibDRUG
docetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Incyte Corporationlead sponsor
Mapped research locations
Los AngelesCalifornia, United States1ClevelandOhio, United States1Washington D.C.District of Columbia, United States1OrlandoFlorida, United States1DetroitMichigan, United States1OmahaNebraska, United States1Kansas CityMissouri, United States1SpartanburgSouth Carolina, United States1LebanonNew Hampshire, United States1HersheyPennsylvania, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02257619 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.